Search results for " Coronaviru"

showing 10 items of 730 documents

Le pharmacien et le consentement éclairé

2021

During the implementation of the Covid-19 vaccination, the issue of consent was widely commented upon. Many confusions arose between the withdrawal period, the obligation to collect written consent and many other more or less fanciful concepts. Informed consent is one of the founding stones of health democracy. It deserves to be understood in order to be intelligently applied.

Pharmacology2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Informed consentmedia_common.quotation_subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)LawPharmacistPharmacology (medical)ObligationPsychologyDemocracymedia_commonActualités Pharmaceutiques
researchProduct

Vaccin contre la Covid-19, une course contre le temps

2021

Pharmacology2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicinePharmacology (medical)businessVirologyArticleActualités Pharmaceutiques
researchProduct

Diabetes and COVID-19: A Tale of 2 Pandemics.

2021

Abstract: Epidemiological studies indicate that diabetes is the second most common comorbidity in COVID-19 (coronavirus disease 2019). Dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, exerts direct cardioprotective and nephroprotective effects. DARE-19 (Dapagliflozin in Respiratory Failure in Patients With COVID-19), an ongoing clinical trial, is designed to investigate the impact of dapagliflozin on COVID-19 progression. This article discusses the potential favorable impact of dapagliflozin on COVID-19 and its complications.

Pharmacology2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)diabetesbusiness.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19Review Articledapagliflozinmedicine.diseaseVirologyDARE-19Diabetes mellitusPandemicmedicineDiabetes MellitusHumansSGLT2iCardiology and Cardiovascular MedicinebusinessPandemicsHumans Pandemics SARS-CoV-2 COVID-19 Diabetes MellitusJournal of cardiovascular pharmacology
researchProduct

The Post-Lockdown Era: What Is Next in Italy?

2020

The current outbreak of the COVID-19 infection, which started in December 2019 in Wuhan (China), was declared a pandemic by the World Health Organization (WHO) on the 11th of March, 2020.

Pharmacology2019-20 coronavirus outbreakOpinionCoronavirus disease 2019 (COVID-19)business.industrydiagnosisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)infectious diseaselcsh:RM1-950COVID-19infectious diseasesVirologymortalitydiagnosilcsh:Therapeutics. PharmacologyautopsyMedicinePharmacology (medical)business
researchProduct

Front Cover: Structure‐Activity Relationships of Benzamides and Isoindolines Designed as SARS‐CoV Protease Inhibitors Effective against SARS‐CoV‐2 (2…

2021

PharmacologyFront coverProteaseChemistrymedicine.medical_treatmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Organic ChemistryDrug DiscoverymedicineMolecular MedicineGeneral Pharmacology Toxicology and PharmaceuticsBiochemistryVirologyChemMedChem
researchProduct

Adverse Reactions to Anti-SARS-CoV-2 Vaccine: A Prospective Cohort Study Based on an Active Surveillance System

2022

To date, Coronavirus disease (COVID-19) has caused high morbidity and mortality worldwide. To counteract the pandemic scenario, several vaccines against the etiological factor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were developed and tested. At the end of December 2020, BNT162b2 (Comirnaty, Pfizer-BioNTech) was the first and only authorized vaccine in Italy for selected categories, such as healthcare workers, fragile patients and people aged over 80 years old. To master our knowledge about BNT162b2 adverse reactions (ARs), an active surveillance system based on instant messaging was realized for voluntary participants who had been vaccinated at COVID-19 Vaccination …

PharmacologySARS-CoV-2Immunologyadverse reactionactive surveillance systemadverse reaction; vaccine; coronavirus; SARS-CoV-2; m-RNA; female; young people; active surveillance systemyoung peoplecoronavirufemaleInfectious DiseasesvaccineDrug DiscoveryPharmacology (medical)m-RNAVaccines
researchProduct

Interfering with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy

2020

Abstract: Due to its fast international spread and substantial mortality, the coronavirus disease COVID-19 evolved to a global threat. Since there is currently no causative drug against this viral infection available, science is striving for new drugs and other approaches to treat the new disease. Studies have shown that the cell entry of coronaviruses into host cells takes place through the binding of the viral spike (S) protein to cell receptors. Priming of the S protein occurs via hydrolysis by different host proteases. The inhibition of these proteases could impair the processing of the S protein, thereby affecting the interaction with the host-cell receptors and preventing virus cell …

PharmacologySerine proteaseCathepsinProteasesbiologySARS-CoV-2Organic ChemistryVirus Internalizationmedicine.disease_causeBiochemistryVirologyTransmembrane proteinVirusCOVID-19 Drug TreatmentSpike Glycoprotein CoronavirusDrug Discoverybiology.proteinmedicineHumansMolecular MedicineSerine ProteasesReceptorFurinCoronavirusCurrent Medicinal Chemistry
researchProduct

Editorial: The Challenge of New Therapeutic Approaches for Unmet Therapeutic Needs

2020

Pharmacologydrug-designmedicine.medical_specialty2019-20 coronavirus outbreakdrug-design; efficacy/risk ratio; innovative therapies; pharmaceutical innovations; pharmacology innovationCoronavirus disease 2019 (COVID-19)business.industrypharmacology innovationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)lcsh:RM1-950lcsh:Therapeutics. PharmacologyInnovative Therapiesinnovative therapiespharmaceutical innovationsmedicinePharmacology (medical)Intensive care medicinebusinessPharmaceutical innovationsefficacy/risk ratio
researchProduct

Lateral flow assays (LFA) as an alternative medical diagnosis method for detection of virus species: The intertwine of nanotechnology with sensing st…

2021

Viruses are responsible for multiple infections in humans that impose huge health burdens on individuals and populations worldwide. Therefore, numerous diagnostic methods and strategies have been developed for prevention, management, and decreasing the burden of viral diseases, each having its advantages and limitations. Viral infections are commonly detected using serological and nucleic acid-based methods. However, these conventional and clinical approaches have some limitations that can be resolved by implementing other detector devices. Therefore, the search for sensitive, selective, portable, and costless approaches as efficient alternative clinical methods for point of care testing (P…

Point of care testingViral infectionsDiagnostic methodsSARS-CoV-2Computer sciencePoint-of-care testingSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)HIVArticleInfluenzaClinical methodAnalytical ChemistryMultiple infectionsVirus detectionDengueZikaRisk analysis (engineering)HBVMedical diagnosisSpectroscopyVirus classificationLateral flow assaysTrAC Trends in Analytical Chemistry
researchProduct

Changes in air pollution during COVID-19 lockdown in Spain: a multi-city study

2021

Highlights • Variations in air quality in terms of CO, SO2, PM10, O3 and NO2 levels were studied • The lockdown of Spain was not able to reduce severe air pollution in all its forms • Significant reductions of NO2 levels were achieved in most cities • Increases of O3 pollution levels were found in several cities

PollutionEnvironmental Engineering010504 meteorology & atmospheric sciencesCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)media_common.quotation_subjectAir pollution010501 environmental sciencesmedicine.disease_cause01 natural sciencesArticlelockdownAir PollutionPandemicmedicineHumansEnvironmental ChemistrypollutionCitiesmeteorologySocioeconomicsAir quality indexPandemics0105 earth and related environmental sciencesMaximum pressuremedia_commonGeneral Environmental ScienceAir PollutantsSmall citySARS-CoV-2COVID-19General Medicineair qualityGeographySpainParticulate MatterEnvironmental MonitoringJournal of Environmental Sciences (China)
researchProduct